Direct Biologics, LLC

From potential use as gene therapy delivery vehicles to anti-inflammatory therapies and cancer drugs, there has been excitement around exosomes since these stem cell components were first observed in

The biopharmaceutical industry cheered Third Harmonic Bio ’s sizeable initial public offering in mid-September but the IPO market in the US has gone quiet since then as broader stock indices – includ

Recent US FDA awards of the regenerative medicine advanced therapy (RMAT) designation highlight the breadth of research activity in the cell and gene therapy space. The RMAT designations range from a